GSK announces leadership changes

Aug 12, 2019

GlaxoSmithKline announced that Jack Bailey, President U.S. Pharmaceuticals, has decided to step down from his role at the end of the year.

Bailey will be succeeded by Maya Martinez-Davis, currently Regional President, Latin America Region at EMD Serono, Merck KGaA's biopharma arm.

Martinez-Davis has a track record of success in bringing new specialty care treatments to patients. Martinez-Davis will join GSK in mid-September and will assume responsibility of the U.S. Pharmaceuticals business at GSK on January 1, 2020.

Read the press release